Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Pharmacology
Cover of the book Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319468778
Publisher: Springer International Publishing Publication: April 7, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319468778
Publisher: Springer International Publishing
Publication: April 7, 2017
Imprint: Springer
Language: English

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.

The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.

The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

More books from Springer International Publishing

Cover of the book Power Estimation on Electronic System Level using Linear Power Models by
Cover of the book Economics Without Laws by
Cover of the book Distributed Embedded Controller Development with Petri Nets by
Cover of the book Sustainable Business Models by
Cover of the book Extreme Sports, Extreme Bodies by
Cover of the book Understanding Novelty in Organizations by
Cover of the book The Archaean Geology of the Kaapvaal Craton, Southern Africa by
Cover of the book New Atheism: Critical Perspectives and Contemporary Debates by
Cover of the book Britain and the Arctic by
Cover of the book The Theory of Laser Materials Processing by
Cover of the book The End of Whitehall? by
Cover of the book Confidentiality and Integrity in Crowdsourcing Systems by
Cover of the book Statistical Atlases and Computational Models of the Heart. ACDC and MMWHS Challenges by
Cover of the book Iran Revisited by
Cover of the book Smart Grid Inspired Future Technologies by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy